# Mesenchymal Stem Cells (MSCs) for Steroid Refractory Acute GVHD (SR-aGVHD)

> **NCT05443464** · PHASE1 · WITHDRAWN · sponsor: **Ossium Health, Inc.**

## Conditions studied

- GVHD,Acute

## Interventions

- **BIOLOGICAL:** OSSM-001

## Key facts

- **NCT ID:** NCT05443464
- **Lead sponsor:** Ossium Health, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2023-06-05
- **Primary completion:** 2024-06-10
- **Final completion:** 2024-10-14
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** OSSM-001 will not be used in this program moving forward.
- **Last updated:** 2022-12-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05443464

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05443464, "Mesenchymal Stem Cells (MSCs) for Steroid Refractory Acute GVHD (SR-aGVHD)". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT05443464. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*